---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-033586"
form_type: "8-K"
ticker: "BBLG"
cik: "0001419554"
company_name: "Bone Biologics Corp"
filed_at: "2026-07-16T21:25:14+00:00"
generated_at: "2026-07-16T21:26:02.630507+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Bone Biologics postpones 2026 annual meeting to September 28, 2026

## Summary
- Annual meeting moved from August 11 to September 28, 2026; new record date August 6, 2026.
- Board cites need for additional time for stockholders to consider proxy materials with an added proposal.
- Stockholder proposal deadline extended to July 26, 2026, ten days after this 8-K filing.
- Meeting location unchanged: 2 Burlington Woods Drive, Ste 100, Burlington, MA at 11:30 a.m. ET.

## SEC filing metadata
- accession: 0001493152-26-033586
- form_type: 8-K
- ticker: BBLG
- cik: 0001419554
- company_name: Bone Biologics Corp
- filed_at: 2026-07-16T21:25:14+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419554/000149315226033586/0001493152-26-033586-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419554/000149315226033586/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-033586
- JSON: https://secwatch.observer/filing/0001493152-26-033586.json
- Plain text: https://secwatch.observer/filing/0001493152-26-033586.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.